Literature DB >> 28106253

Massive plasmablast response elicited in the acute phase of hantavirus pulmonary syndrome.

Marina García1, Ayelén Iglesias2, Verónica I Landoni3, Carla Bellomo2, Agostina Bruno4, María Teresa Córdoba4, Luciana Balboa1, Gabriela C Fernández3, María Del Carmen Sasiain1, Valeria P Martínez2, Pablo Schierloh1.   

Abstract

Beside its key diagnostic value, the humoral immune response is thought to play a protective role in hantavirus pulmonary syndrome. However, little is known about the cell source of these antibodies during ongoing human infection. Herein we characterized B-cell subsets circulating in Andes-virus-infected patients. A notable potent plasmablast (PB) response that increased 100-fold over the baseline levels was observed around 1 week after the onset of symptoms. These PB present a CD3neg CD19low CD20neg CD38hi CD27hi CD138+/- IgA+/- surface phenotype together with the presence of cytoplasmic functional immunoglobulins. They are large lymphocytes (lymphoblasts) morphologically coincident with the 'immunoblast-like' cells that have been previously described during blood cytology examinations of hantavirus-infected patients. Immunoreactivity analysis of white blood cell lysates suggests that some circulating PB are virus-specific but we also observed a significant increase of reactivity against virus-unrelated antigens, which suggests a possible bystander effect by polyclonal B-cell activation. The presence of this large and transient PB response raises the question as to whether these cells might have a protective or pathological role during the ongoing hantavirus pulmonary syndrome and suggest their practical application as a diagnostic/prognostic biomarker.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  Andes virus; B cell; hantavirus pulmonary syndrome; plasmablast; polyclonal activation

Mesh:

Substances:

Year:  2017        PMID: 28106253      PMCID: PMC5382343          DOI: 10.1111/imm.12713

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  49 in total

1.  Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect.

Authors:  F Eun-Hyung Lee; Jessica L Halliley; Edward E Walsh; Andrew P Moscatiello; Brittany L Kmush; Ann R Falsey; Troy D Randall; Denise A Kaminiski; Richard K Miller; Iñaki Sanz
Journal:  J Immunol       Date:  2011-03-25       Impact factor: 5.422

2.  A novel mu-capture enzyme-linked immunosorbent assay based on recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome.

Authors:  L G Zöller; S Yang; P Gött; E K Bautz; G Darai
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

3.  Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.

Authors:  Gui-Mei Li; Christopher Chiu; Jens Wrammert; Megan McCausland; Sarah F Andrews; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Xinyan Qu; Srilatha Edupuganti; Mark Mulligan; Suman R Das; Jonathan W Yewdell; Aneesh K Mehta; Patrick C Wilson; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

4.  Western analysis of intracellular interleukin-8 in human mononuclear leukocytes.

Authors:  Veronika Miskolci; Louis Hodgson; Dianne Cox; Ivana Vancurova
Journal:  Methods Mol Biol       Date:  2014

5.  Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response.

Authors:  Marcus Odendahl; Henrik Mei; Bimba F Hoyer; Annett M Jacobi; Arne Hansen; Gwendolin Muehlinghaus; Claudia Berek; Falk Hiepe; Rudi Manz; Andreas Radbruch; Thomas Dörner
Journal:  Blood       Date:  2004-10-26       Impact factor: 22.113

6.  Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America.

Authors:  P J Padula; S B Colavecchia; V P Martínez; M O Gonzalez Della Valle; A Edelstein; S D Miguel; J Russi; J M Riquelme; N Colucci; M Almirón; R D Rabinovich
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

7.  A retrospective serologic survey of hantavirus infections in the county of Cássia dos Coqueiros, State of São Paulo, Brazil.

Authors:  Soraya Jabur Badra; Felipe Gonçalves Mota Maia; Glauciane Garcia Figueiredo; Gilberto Sabino Dos Santos Junior; Gelse Mazzoni Campos; Luiz Tadeu Moraes Figueiredo; Afonso Dinis Costa Passos
Journal:  Rev Soc Bras Med Trop       Date:  2012-07-05       Impact factor: 1.581

8.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

9.  Blood-borne human plasma cells in steady state are derived from mucosal immune responses.

Authors:  Henrik E Mei; Taketoshi Yoshida; Wondossen Sime; Falk Hiepe; Kathi Thiele; Rudolf A Manz; Andreas Radbruch; Thomas Dörner
Journal:  Blood       Date:  2008-11-05       Impact factor: 22.113

10.  Hantavirus pulmonary syndrome, Southern Chile, 1995-2012.

Authors:  Raúl Riquelme; María Luisa Rioseco; Lorena Bastidas; Daniela Trincado; Mauricio Riquelme; Hugo Loyola; Francisca Valdivieso
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

View more
  19 in total

1.  A Protein Epitope Targeted by the Antibody Response to Kawasaki Disease.

Authors:  Anne H Rowley; Susan C Baker; David Arrollo; Leah J Gruen; Tetyana Bodnar; Nancy Innocentini; Matthew Hackbart; Yazmin E Cruz-Pulido; Kristine M Wylie; Kwang-Youn A Kim; Stanford T Shulman
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

2.  Increased circulating PD-1hiCXCR5- peripheral T helper cells are associated with disease activity of ANCA-associated vasculitis.

Authors:  Zhenyu Liu; Xueqin Li; Ningning Fan; Hong Wang; Wenli Xia; Wenjie Li; Sha Tang; Xinyuan Zhou; Yuzhang Wu; Liyun Zou; Jingyi Li; Jingbo Zhang
Journal:  Clin Exp Immunol       Date:  2022-05-12       Impact factor: 4.330

3.  Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naïve and DENV-Exposed Individuals in a Brazilian Cohort.

Authors:  Cássia G T Silveira; Diogo M Magnani; Priscilla R Costa; Vivian I Avelino-Silva; Michael J Ricciardi; Maria do Carmo S T Timenetsky; Raphaella Goulart; Carolina A Correia; Mariana P Marmorato; Lilian Ferrari; Zelinda B Nakagawa; Claudia Tomiyama; Helena Tomiyama; Jorge Kalil; Ricardo Palacios; Alexander R Precioso; David I Watkins; Esper G Kallás
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

4.  Increased Circulating PD-1 hi CXCR5 - Peripheral T Helper Cells are Associated with Disease Activity of ANCA-Associated Vasculitis.

Authors:  Zhenyu Liu; Xueqin Li; Ningning Fan; Hong Wang; Wenli Xia; Wenjie Li; Sha Tang; Xinyuan Zhou; Yuzhang Wu; Liyun Zou; Jingyi Li; Jingbo Zhang
Journal:  Clin Exp Immunol       Date:  2022-01-12       Impact factor: 5.732

5.  Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.

Authors:  Renata Varnaitė; Marina García; Hedvig Glans; Kimia T Maleki; John Tyler Sandberg; Janne Tynell; Wanda Christ; Nina Lagerqvist; Hilmir Asgeirsson; Hans-Gustaf Ljunggren; Gustaf Ahlén; Lars Frelin; Matti Sällberg; Kim Blom; Jonas Klingström; Sara Gredmark-Russ
Journal:  J Immunol       Date:  2020-09-02       Impact factor: 5.422

6.  Identifying target cells for a tick-borne virus that causes fatal hemorrhagic fever.

Authors:  Satoko Yamaoka; Carla Weisend; Hideki Ebihara
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

7.  MAIT cell activation is associated with disease severity markers in acute hantavirus infection.

Authors:  Kimia T Maleki; Johanna Tauriainen; Marina García; Priscilla F Kerkman; Wanda Christ; Joana Dias; Julia Wigren Byström; Edwin Leeansyah; Mattias N Forsell; Hans-Gustaf Ljunggren; Clas Ahlm; Niklas K Björkström; Johan K Sandberg; Jonas Klingström
Journal:  Cell Rep Med       Date:  2021-03-16

Review 8.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

9.  Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease.

Authors:  Meghan Martin; Brian H Wrotniak; Mark Hicar
Journal:  PLoS One       Date:  2018-03-26       Impact factor: 3.240

10.  Generation of plasma cells and CD27-IgD- B cells during hantavirus infection is associated with distinct pathological findings.

Authors:  Priscilla F Kerkman; Andy Dernstedt; Lalitha Tadala; Eva Mittler; Mirjam Dannborg; Christopher Sundling; Kimia T Maleki; Johanna Tauriainen; Anne Tuiskunen-Bäck; Julia Wigren Byström; Pauline Ocaya; Therese Thunberg; Rohit K Jangra; Gleyder Román-Sosa; Pablo Guardado-Calvo; Felix A Rey; Jonas Klingström; Kartik Chandran; Andrea Puhar; Clas Ahlm; Mattias Ne Forsell
Journal:  Clin Transl Immunology       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.